Larvol Delta - Study-of-Adjuvant-Darovasertib-and-Crizotinib-in-Participants-With-Primary-Nonmetastatic-Uveal-Melanoma

Xalkori (crizotinib) - Pfizer

darovasertib (IDE196) - Ideaya Biosci

http://clinicaltrials.gov/ct2/show/NCT07804186

Sep 5, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next